Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
Phase 4
Completed
- Conditions
- CataractDry Eye
- Registration Number
- NCT00349583
- Lead Sponsor
- Innovative Medical
- Brief Summary
The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-
· Males or females > 50 years old
- Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion Criteria
-
· Prior use of topical cyclosporine
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cyclosporine's efficacy in improving visual outcomes after multifocal IOL implantation?
How does topical cyclosporine compare to standard tear therapy in managing dry eye post-cataract surgery with multifocal IOLs?
Are there specific biomarkers that predict response to cyclosporine treatment in patients with dry eye following multifocal IOL implantation?
What are the known adverse events associated with cyclosporine use in post-cataract surgery patients and how are they managed?
What related compounds or combination therapies are being explored for dry eye management in multifocal IOL recipients?
Trial Locations
- Locations (1)
Ophthalmic Consultants of Long Island
🇺🇸Rockville Centre, New York, United States
Ophthalmic Consultants of Long Island🇺🇸Rockville Centre, New York, United States